Inactive Instrument

All News Global Blood Therapeutics, Inc.

Equities

GBT

US37890U1088

All News

Unlock all the news: Be the first to know and act before the market!

Pfizer Completes $5.4 Billion Acquisition Of Sickle Cell Disease Drug Innovator	22-10-27	AQ
BioPharma Credit Receives $175 Million From Global Blood Therapeutics Investment	22-10-06	MT
Global Blood Therapeutics, Inc.(NasdaqGS:GBT) dropped from S&P Global BMI Index	22-10-06	CI
Global Blood Therapeutics, Inc.(NasdaqGS:GBT) dropped from S&P TMI Index	22-10-06	CI
Global Blood Therapeutics, Inc.(NasdaqGS:GBT) dropped from S&P Biotechnology Select Industry Index	22-10-06	CI
GLOBAL BLOOD THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Regi (form 8-K)	22-10-05	AQ
Global Blood Therapeutics, Inc. Announces Cessation of Ted W. Love as Chief Executive Officer	22-10-05	CI
Global Blood Therapeutics, Inc. Announces Executive Changes	22-10-05	CI
Global Blood Therapeutics, Inc.(NasdaqGS:GBT) dropped from NASDAQ Composite Index	22-10-05	CI
Pfizer Inc. completed the acquisition of Global Blood Therapeutics, Inc. from a group of shareholders.	22-10-04	CI
Global Blood Therapeutics, Inc.(NasdaqGS:GBT) dropped from NASDAQ Biotechnology Index	22-10-04	CI
GLOBAL BLOOD THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)	22-09-30	AQ
GLOBAL BLOOD THERAPEUTICS, INC. : Other Events (form 8-K)	22-09-23	AQ
GBT Supports the Sickle Cell Disease Treatment Centers Act of 2022	22-09-15	AQ
GBT and Sickle Cell Disease Association of America to Host 11th Annual Sickle Cell Disease Therapeutics Conference	22-09-08	AQ
Insider Sell: Global Blood Therapeutics	22-09-07	MT
GLOBAL BLOOD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Global Blood Therapeutics, Inc. - GBT	22-08-31	BU
Insider Sell: Global Blood Therapeutics	22-08-19	MT
Biotech stocks pin bounce back hopes on M&A boost	22-08-12	RE
North American Morning Briefing : Caution -2-	22-08-10	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Global Blood Therapeutics, Inc.

Equities

GBT

US37890U1088

All News

Filters